2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one

C118H145N27O13S — CID 158902542

IUPAC2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one
SMILESCC(C)(O)c1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1.CCOc1nccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.Cc1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ccn1.Cc1csc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.O=c1nccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)[nH]1
InChIInChI=1S/C26H33N5O3.C24H30N6O3.C24H29N5O2.C22H26N6O3.C22H27N5O2S/c1-26(2,32)18-3-8-24(29-17-18)30-19-4-6-21(7-5-19)34-23-16-20(31-11-13-33-14-12-31)15-22-25(23)28-10-9-27-22;1-2-32-24-27-8-7-22(29-24)28-17-3-5-19(6-4-17)33-21-16-18(30-11-13-31-14-12-30)15-20-23(21)26-10-9-25-20;1-17-14-19(6-7-25-17)28-18-2-4-21(5-3-18)31-23-16-20(29-10-12-30-13-11-29)15-22-24(23)27-9-8-26-22;29-22-25-6-5-20(27-22)26-15-1-3-17(4-2-15)31-19-14-16(28-9-11-30-12-10-28)13-18-21(19)24-8-7-23-18;1-15-14-30-22(25-15)26-16-2-4-18(5-3-16)29-20-13-17(27-8-10-28-11-9-27)12-19-21(20)24-7-6-23-19/h3,8-10,15-17,19,21,32H,4-7,11-14H2,1-2H3,(H,29,30);7-10,15-17,19H,2-6,11-14H2,1H3,(H,27,28,29);6-9,14-16,18,21H,2-5,10-13H2,1H3,(H,25,28);5-8,13-15,17H,1-4,9-12H2,(H2,25,26,27,29);6-7,12-14,16,18H,2-5,8-11H2,1H3,(H,25,26)
InChIKeyJFPYVZNTPYOHKY-UHFFFAOYSA-N
MW2181.70 g/mol
LogP17.71
Rot. Bonds28

About 2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one

2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one (PubChem CID 158902542) has the molecular formula C118H145N27O13S and a molecular weight of 2181.70 g/mol. Its IUPAC name is 2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one.

Molecular Properties

Compound Name2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one
PubChem CID158902542
Molecular FormulaC118H145N27O13S
Molecular Weight2181.70 g/mol
Exact Mass2180.12
IUPAC Name2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one
SMILESCC(C)(O)c1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1.CCOc1nccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.Cc1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ccn1.Cc1csc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.O=c1nccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)[nH]1
InChIInChI=1S/C26H33N5O3.C24H30N6O3.C24H29N5O2.C22H26N6O3.C22H27N5O2S/c1-26(2,32)18-3-8-24(29-17-18)30-19-4-6-21(7-5-19)34-23-16-20(31-11-13-33-14-12-31)15-22-25(23)28-10-9-27-22;1-2-32-24-27-8-7-22(29-24)28-17-3-5-19(6-4-17)33-21-16-18(30-11-13-31-14-12-30)15-20-23(21)26-10-9-25-20;1-17-14-19(6-7-25-17)28-18-2-4-21(5-3-18)31-23-16-20(29-10-12-30-13-11-29)15-22-24(23)27-9-8-26-22;29-22-25-6-5-20(27-22)26-15-1-3-17(4-2-15)31-19-14-16(28-9-11-30-12-10-28)13-18-21(19)24-8-7-23-18;1-15-14-30-22(25-15)26-16-2-4-18(5-3-16)29-20-13-17(27-8-10-28-11-9-27)12-19-21(20)24-7-6-23-19/h3,8-10,15-17,19,21,32H,4-7,11-14H2,1-2H3,(H,29,30);7-10,15-17,19H,2-6,11-14H2,1H3,(H,27,28,29);6-9,14-16,18,21H,2-5,10-13H2,1H3,(H,25,28);5-8,13-15,17H,1-4,9-12H2,(H2,25,26,27,29);6-7,12-14,16,18H,2-5,8-11H2,1H3,(H,25,26)
InChIKeyJFPYVZNTPYOHKY-UHFFFAOYSA-N
XLogP17.71
TPSA437.21 Ų
H-Bond Donors7
H-Bond Acceptors40
Rotatable Bonds28
Heavy Atoms159
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002181.70
LogP ≤ 517.71
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1040

Analyze 2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one?
The IUPAC name of 2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one (CID 158902542) is 2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one.
What is the SMILES notation for 2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one?
The canonical SMILES for 2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one is CC(C)(O)c1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1.CCOc1nccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.Cc1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ccn1.Cc1csc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.O=c1nccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)[nH]1.
What is the InChIKey of 2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one?
The InChIKey is JFPYVZNTPYOHKY-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H33N5O3.C24H30N6O3.C24H29N5O2.C22H26N6O3.C22H27N5O2S/c1-26(2,32)18-3-8-24(29-17-18)30-19-4-6-21(7-5-19)34-23-16-20(31-11-13-33-14-12-31)15-22-25(23)28-10-9-27-22;1-2-32-24-27-8-7-22(29-24)28-17-3-5-19(6-4-17)33-21-16-18(30-11-13-31-14-12-30)15-20-23(21)26-10-9-25-20;1-17-14-19(6-7-25-17)28-18-2-4-21(5-3-18)31-23-16-20(29-10-12-30-13-11-29)15-22-24(23)27-9-8-26-22;29-22-25-6-5-20(27-22)26-15-1-3-17(4-2-15)31-19-14-16(28-9-11-30-12-10-28)13-18-21(19)24-8-7-23-18;1-15-14-30-22(25-15)26-16-2-4-18(5-3-16)29-20-13-17(27-8-10-28-11-9-27)12-19-21(20)24-7-6-23-19/h3,8-10,15-17,19,21,32H,4-7,11-14H2,1-2H3,(H,29,30);7-10,15-17,19H,2-6,11-14H2,1H3,(H,27,28,29);6-9,14-16,18,21H,2-5,10-13H2,1H3,(H,25,28);5-8,13-15,17H,1-4,9-12H2,(H2,25,26,27,29);6-7,12-14,16,18H,2-5,8-11H2,1H3,(H,25,26).
What are the key properties of 2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one?
2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one has a molecular weight of 2181.70 g/mol, XLogP of 17.71, 28 rotatable bonds, 7 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for 2-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;2-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-4-amine;4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazol-2-amine;2-[6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-3-pyridinyl]propan-2-ol;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-1H-pyrimidin-2-one is sourced from PubChem (CID 158902542), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).